Market Research Logo

Global Acne Treatment Market: Size, Trends & Forecasts (2016 Edition)

Global Acne Treatment Market: Size, Trends & Forecasts (2016 Edition)

Scope of the Report

The report entitled “Global Acne Treatment Market: Size, Trends & Forecasts (2016 Edition)”, provides analysis of the global acne treatment market and its products, with detailed analysis of market size and growth in terms of value. The report also provides in brief about the market split. The global acne treatment market can be divided into seven segments: Antibiotics, Non-Inflammatory, Antimicrobials, Combination Medications, Hormonal Agents, Oral Retinoid, and Topical Retinoid.

The report also provides a detailed analysis of prescription drugs available in the market for acne treatment. Details of SOLODYN, EPIDUO, ABSORICA, ACZONE and DORYX has provided in terms of their worldwide sales.

The report includes the detailed regional analysis, covering market size and growth for global acne treatment market for the following regions: the US and Asia Pacific. The US is the largest market for acne treatment in terms of value.

Growth of the overall global acne treatment market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The global acne treatment market is highly fragmented with a large number of niche players. Company profiling of Foamix Pharmaceuticals Ltd., Valeant Pharmaceuticals, Dermira and Allergan (Actavis Plc) has provided in the report. Company profiling is based on attributes like business overview, financial overview and strategies adopted by these companies in order to grow in the market.

Country Coverage

The US
Asia Pacific

Company Coverage

Foamix Pharmaceuticals Ltd.
Valeant Pharmaceuticals
Allergan (Actavis Plc)

Executive Summary

Acne is a disorder in the skin that is caused by inflammation of the skin glands and hair follicles and is characterized by comedones and pimples specifically in certain areas like on the face, back and chest etc. During acne, sebaceous glands become clogged and infected which result in the formation of acne. It is most commonly found in teenagers and adolescents but also occurs in infants and adults. Depending on its severity, acne can cause emotional distress and scar the skin. Acne Vulgaris is the medical term for common acne. Acne can be mild, moderate or severe.

There are four main causes of acne vulgaris: hyper-keratinization, excess sebum production, bacteria Propionibacterium and inflammation. Dermatologists have the most experience treating different types of acne. On the basis of severity, there are six types of acne: Acne Rosacea, Acne Cosmetica, Acne Fulminans, Acne Keloidalis Nuchae (AKN), Acne Chloracne and Acne Medicamentosa. Several treatments are available in the market nowadays with effective results. Acne can be treated through three therapies namely systematic therapy, topical therapy and physical therapy. Currently acne treatment market is dominated by topical therapy or topical drugs that are widely used by large number of population for acne treatment.

The global acne treatment market is growing rapidly over the years and is expected to increase further in the forecasted period (2016-2020). Global acne treatment is supported by a number of growth drivers such as rising disposable income, high global prevalence rate of acne, unhealthy eating habits and increasing awareness in teenagers regarding acne treatment etc. Yet, there are certain challenges such as entry of generic drugs, safety issue regarding products and increasing acceptance of ant-acne treatment etc. that hinder the growth of the market.

1. Executive Summary
2. Introduction
2.1 Overview of Acne
2.1.1 Causes of Acne Vulgaris
Table 1: Cause of Acne Vulgaris
2.2 Types of Acne
Acne Rosacea
Acne Cosmetica
Acne Fulminans
Acne Keloidalis Nuchae
Acne Chloracne
Acne Medicamentosa
Table 2: Types of Acne
2.3 Acne Treatment
Table 3: Acne Treatment Paradigms
3. Global Market Analysis
3.1 Global Acne Treatment Market: An Analysis
3.1.1 Global Dermatology Market
Table 4: Global Dermatology Market by Value; 2015-2020E (US$ Billion)
3.1.2 Global Acne Treatment Market by Value
Table 5: Global Acne Treatment Market by Value; 2014-2015E (US$ Billion)
Table 6: Global Acne Treatment Market by Value; 2016-2020E (US$ Billion)
3.2 Global Acne Market Split
Table 7: Acne Treatment Market Split
4. Product Analysis
4.1 Global Prescription Drugs
4.1.1 SOLODYN (Minocycline Hydrochloride)
Table 8: Penetration of Total Solodyn vs Generic Minocycline; 2014-2020E
Table 9: SOLODYN Global Sales; 2010-2014 (US$ Million)
4.1.2 EPIDUO (Adapalene 0.1%, Benzoyl Peroxide 2.5%)
Table 10: EPIDUO Global Sales; 2014-2015 (US$ Million)
Table 11: Preferred Topical Therapy; 2014
4.1.3 DORYX (Doxycycline Heclate)
Table 12: DORYX Global Sales; 2014-2015 (US$ Million)
Table 13: ABSORICA Revenue Share; 2015
Table 14: ABSORICA Global Sales; 2015
4.1.5 ACZONE
Table 15: ACZONE Global Sales; 2015
4.2 Over the Counter Products
Table A: Common Topical OTC Products for Acne Treatment
5. Country/Regional Analysis
5.1 The US Acne Treatment Market: An Analysis
5.1.1 The US Acne Treatment Market by Value
Table 16: US Acne Treatment Market by Value; 2014-2015E (US$ Billion)
Table 17: US Acne Treatment Market by Value; 2016-2020E (US$ Billion)
5.1.2 The US Acne Treatment Market by Segment
Table 18: US Acne Treatment Market by Segment; 2014
5.2 Asia Pacific Acne Treatment Market: An Analysis
5.2.1 Asia Pacific Acne Treatment Market by Value
Table 19: Asia Pacific Acne Treatment Market by Value; 2011-2015E (US$ Million)
Table 20: Asia Pacific Acne Treatment Market by Value; 2016-2020E; (US$ Million)
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Rise in Disposable Income
Table 21: Global GNI per Capita; 2010-2014 (US$)
6.1.2 High Global Prevalence Rate of Acne
Table 22: Prevalence Rate of Acne; 2014
6.1.3 Unhealthy Eating Habits
Table 23: World’s Top 10 Obese Countries; 2014
6.1.4 Increasing Awareness in Teenagers
6.1.5 Increasing Rate of Sedentary Lifestyle
6.2 Challenges
6.2.1 Entry of Generic Drugs
6.2.2 Safety Issue Regarding Products
6.2.3 Increasing Acceptance of Alternative Acne Treatment
6.2.4 Regulatory Issues
6.2.5 High Cost of Drugs
6.2.6 Increasing Competition
6.3 Market Trends
6.3.1 Laser Treatment
6.3.2 Technology-Driven Products
6.3.3 Efficacy Concern on Current Drugs
6.3.4 Shift towards Combination Products
7. Competitive Landscape
Table B: Dermatology Company Valuations; 2015
8. Company Profiling
8.1 Foamix Pharmaceuticals Ltd.
8.1.1 Business Overview
8.1.2 Financial Overview
Table 24: Foamix Pharmaceuticals Ltd. Revenue; 2012-2015 (US$ Million)
8.1.3 Business Strategy
8.2 Valeant Pharmaceuticals
8.2.1 Business Overview
Table C: Valeant Product Launches; 2014
8.2.2 Financial Overview
Table 25: Valeant Pharmaceuticals Revenue; 2011-2015E (US$ Billion)
Table 26: Valeant Revenue by Segment; 2014
8.2.3 Business Strategy
8.3 Dermira
8.3.1 Business Overview
Table D: Important Dermira Product Catégories
8.3.2 Financial Overview
Table 27: Dermira Expected Revenue; 2015-2020E (US$ Million)
Table E: Analysis of Dermira’s DRM01 for Acne
8.3.3 Business Strategy
8.4 Allergan (Actavis Plc)
8.4.1 Business Overview
Table F: Actavis Specialty Brands Research and Development
8.4.2 Financial Overview
Table 28: Actavis Plc Revenue; 2010-2014 (US$ Billion)
Table 29: Actavis Plc Revenue Segmentation; 2014
8.4.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook